This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Gynecological Laparoscopy
and you are
between 18 and 80
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

In our prospective, randomized, placebo controlled and double-blinded study we will study the efficacy of intraperitoneal ropivacaine nebulization on pain relief during gynecologic laparoscopic surgery. This is a second steady with protocol of general anesthesia used of Remifentanil.

Provided treatments

  • Drug: 10 mLRopivacaine 1%
  • Drug: Water for injection
  • Drug: 10 mL Ropivacaine 1%
Tris trial is registered with FDA with number: NCT00927979. The sponsor of the trial is Carmel Medical Center and it is looking for 40 volunteers for the current phase.
Official trial title:
Phase 3 Prospective, Randomized, Controlled and Double-blinded Second Trial on Pain Relief by Continuous Intra-peritoneal Nebulization of Ropivacaine Under Remifentanil Anesthesia, During Gynecological Laparoscopic Surgery